help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kishida, M.
Right arrow Articles by Callard, G. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kishida, M.
Right arrow Articles by Callard, G. V.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
Medline Plus Health Information
*Seniors' Health
Endocrinology Vol. 142, No. 2 740-750
Copyright © 2001 by The Endocrine Society


ARTICLES

Distinct Cytochrome P450 Aromatase Isoforms in Zebrafish (Danio rerio) Brain and Ovary Are Differentially Programmed and Estrogen Regulated during Early Development1

Mitsuyo Kishida and Gloria V. Callard

Department of Biology, Boston University, Boston, Massachusetts 02215

Address all correspondence and requests for reprints to: Gloria V. Callard, Ph.D., Department of Biology, Boston University, 5 Cummington Street, Boston, Massachusetts 02215. E-mail: gvc{at}bio.bu.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
As a first step toward understanding estrogen’s role in neurodevelopment, a PCR cloning strategy was used to isolate complementary DNAs encoding two distinct cytochrome P450 aromatase isoforms in adult zebrafish (Danio rerio) brain and ovary (termed P450aromB and P450aromA, respectively). Sequence and phylogenetic analysis showed that the zebrafish P450arom forms are orthologs of previously identified cyp19b and cyp19a genes in goldfish. On Northern blots, a single 4.4-kb transcript of the P450aromB subtype was identified in brain, and a 2.1-kb transcript of the P450aromA subtype in ovary, but RT-PCR showed a degree of overlapping expression. Both messenger RNA (mRNA) forms were detected in unfertilized eggs and 1.5 hpf (cleavage stage) embryos but declined by 12 hpf, indicating maternal transfer. A secondary rise in mRNAs between 12–24 hpf indicated the onset of embryonic cyp19b and -a transcription. Both mRNA species accumulated progressively to 120 hpf (early larval stage), but the relative magnitude and pattern of change was isoform specific. Estradiol (E2, 1 µM) advanced and amplified the developmentally programmed accumulation of P450aromB mRNA, and ICI164.384 decreased expressed levels, implying blockade of an endogenous estrogen mediated regulatory component. Conversely, E2 had no effect or decreased P450aromA mRNA. The early embryonic expression of P450aromB and P450aromA isoforms, and differences in developmental programming and estrogen regulation, imply independent regulatory mechanisms and unique functions during major morphogenetic and differentiative events.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IT IS WELL established that the brain is an estrogen target, and that many of estrogen’s actions are mediated by classical nuclear estrogen receptors (ER) (1). Although estrogen is generally regarded as a circulating hormone derived from the gonads, access of estrogen to target sites within the brain can be limited by high levels of plasma estrogen binding protein or neural estrogen metabolizing enzymes. Thus, certain neural actions of estrogen are dependent on the aromatization of circulating androgen to estrogen in the brain itself. Estrogen formation in the brain and other estrogen synthesizing tissues is catalyzed by cytochrome P450 aromatase (P450arom), a product of the cyp19 gene (2). The first identification of P450arom enzyme activity in the hypothalamus, preoptic area (HPOA) and limbic system of the newborn rodent and human (3), led to research showing that neural ER occupancy is dependent on the neuroanatomic location and timing of aromatase activity (1). Although the majority of studies in rodents have focused on estrogen biosynthesis and actions in reproductive control centers during the perinatal critical period of brain sex differentiation, a time when aromatase peaks in the HPOA, neural expression of P450arom and ER begins earlier than the perinatal period of development, continues in adult and aging brain, and is present in regions outside reproductive control centers (1, 4). Additionally, experiments show that estrogen regulates neuronal proliferation, survival, morphology, synaptogenesis, and differentiated functions in many different regions of the adult brain (1). Recently, estrogen replacement therapy was reported to improve cognitive functions in postmenopausal women and to attenuate and delay the progression of Alzheimer’s and Parkinson’s disease (5). Taken together, the data suggest that estrogen may have a wider role and heretofore unrecognized functions as a general neuroregulatory factor.

Teleost fish are ideal experimental models to investigate the importance of brain-formed (neuro-) estrogen in lifelong processes of neurodevelopment and neuroplasticity. Exaggerated levels of neural P450arom expression are found in all teleost species examined to date. For example, aromatase enzyme activity in goldfish HPOA is 100- to 1000-fold higher than in corresponding regions of adult or fetal rat, mouse, rabbit, and human brain and 10-fold higher than in goldfish ovary (6). In addition to HPOA, aromatase enzyme activity and immunolabeled neurons, tracts, fibers, and terminals are widely distributed in the retina, visual processing areas of the optic tectum, and identified sensory and premotor pathways of the telencephalon, midbrain, hindbrain, and spinal cord (6, 7, 8). It may be relevant that the brain of adult fish retains a remarkable potential for neurogenesis. Not only does the brain continue to grow throughout life, but connections are continually remodeled to accommodate the expansion, and functional regeneration can occur after neural damage, a property that has been especially well studied in the fish visual system (9). In contrast to the human cyp19 gene, which is believed to occur as a single copy in the haploid genome and has multiple tissue-specific promoters and first exons (2), the goldfish has at least two separate and distinct cyp19 loci (10). cyp19b/P450aromB is constitutively expressed at high levels in the brain and is further up-regulated by estrogen, which is the basis for 6- to 8-fold seasonal variations in enzyme protein and messenger RNA (mRNA) (6, 11, 12). cyp19a/P450aromA is expressed in ovary where enzyme levels and mRNA are relatively low (6, 10). If neuroestrogen functions as a neurotrophic factor, we reasoned that the neural P450aromB isoform would be expressed in early stages of CNS development when the rate of neuronal proliferation and differentiation are high. Although taxonomically related to the goldfish, the zebrafish (Danio rerio) has additional advantages as a developmental and genetic model system, and the morphology and regulation of the developing CNS has been especially well documented (13). As a first step in defining a role for neuroestrogen in brain development, we have isolated and characterized complementary DNAs (cDNAs) encoding the zebrafish orthologs of P450aromB and P450aromA; determined patterns of expression by tissue-type in adult fish and at defined developmental stages in embryos and larvae; and demonstrated that an estrogen response system, as measured by up-regulation of P450aromB (but not P450aromA mRNA), is functional as early as 24 h postfertilization (hpf).


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Three- to 5-month-old zebrafish were purchased from Ekk Will Waterlife Resources (Gibsonton, FL) and kept at 26–27 C in aquaria with recirculating deionized water conditioned with Aqualab I Conditioner (Mardel Laboratories, Glendale Heights, IL; pH 7.0). The light regime was 14-h light, 10-h dark (lights on at 0900 h). Fish were fed with Tetra Ruby formulated flake (Tetra, Melle, Germany) twice daily, and with dried quills, Spirulina, and brine shrimp at random. To obtain staged embryos, fish were bred as previously described (13). In brief, at about 1700 h on the day before spawning adult zebrafish (8–10 of each sex) were placed in a plastic mesh cage suspended in a 34 liter breeding tank at 28.5 C. Within 30 min after lights-on the next day, fertilized eggs were siphoned from the bottom of the tank and rinsed extensively in 0.006% Instant Ocean (Aquarium Systems, Mentor, OH) in deionized water (embryo medium) to remove debris. Embryos were allowed to develop at 28.5 C in embryo medium, which was replaced daily. Embryos hatched between 72 and 96 hpf (termed larvae thereafter). Embryos and larvae are of indeterminate sex because gonads develop initially as ovaries (10–12 days) with differentiation to testes in approximately 50% of fish at 23–25 days of age (14). For embryo treatment experiments, stock solutions of estradiol-l7ß (E2; Steraloids, Wilton, NH) and the estrogen antagonist ICI164.384 (ICI; AstraZeneca, Wilmington, DE) were prepared in ethanol and diluted in embryo medium to the final concentration indicated (<0.11% ethanol final concentration). Based on a dose-response study, which showed that 0.1–1.0 µM E2 gave a maximum increase of P450aromB mRNA (15), and reports that estrogen is sequestered in yolk (16) and extensively metabolized and conjugated by fish embryos (17, 18), we chose an estradiol concentration of 1 µM, with replacement at 24-h intervals for the present study. This concentration has no adverse effect on mortality, hatching, or gross morphology (15). Ethanol alone was the treatment control. Treatment began at 2 hpf and continued for the time specified up to 3 weeks post fertilization, with replacement of embryo medium plus/minus additive each 24 h. In washout experiments, treated embryos were washed extensively in embryo medium before resuming development in steroid-free conditions for the time indicated.

Sample collection and RNA extraction
Adult fish were killed by decapitation after anesthetizing in 0.02% 2-phenoxyethanol. For each RNA preparation, brain, eye, liver, and muscle were pooled from ten adult fish of mixed sex; ovaries and testes were pooled separately. Unfertilized eggs were obtained by manually stripping gravid females and approximately 200 used for each RNA extract. Embryos and larvae were killed by quick-freezing on dry ice. For each RNA preparation, 200 embryos were collected at 1.5–2, 6, and 12 hpf, 50 embryos at 24 and 48 hpf, 30 embryos at 72 hpf, 25 larvae at 96 hpf, and 20 larvae at 120 hpf and subsequent time points. The Totally RNA kit (Ambion, Inc. Austin, TX) was used for adult tissues and RNAqueous kit (Ambion, Inc.) for eggs, embryos and larvae. Extracts from 12 hpf or older were treated with DNase I (Promega Corp., Madison, WI).

Oligonucleotides
Oligonucleotides (Ransom Hill Bioscience, Ramona, CA) used as PCR primers (nos. 1–10, 13, 14) and hybridization probes (nos. 11, 12, 15) are listed below. Nucleotide (nt) numbering is based on our reported GenBank sequences (accession numbers AF226619 and AF226620 for P450aromB and A, respectively) and AF025305 for zebrafishß-actin. Oligonucleotides nos. 1 and 2 were degenerate primers used for both brain and ovarian cDNAs and designed to target sequences in highly conserved I-helix and heme-binding regions of previously identified vertebrate P450arom sequences (10). Oligonucleotides nos. 3–15 were gene specific. IUB group codes were used for degenerate primers (D = A+G+T; S = G+C; n = A+G+C+T; Y = C+T; R = A+G; K = G+T; B = G+T+C; V = G+A+C; W = A+T).

No. 1: nt 959–984 (A), 962–987 (B): 5'-CARTGYRTNYTNGARATGNTNATHGC-3'.

No. 2: nt 1382–1402 (A), 1385–1405 (B): 5'-CACCATNGCDATRWRYTTNCC 3-'.

No. 3: nt 1048–1075: 5'-TGCTGTGGAAGAGCAAATCGTACAGGAG- 3'.

No. 4: nt 1341–1367: 5'-CACAACCGAATGGCTGGAAGTAACGAC-3'.

No. 5: nt 1060–1081: 5'-GCAAATCGTACAGGAGATACAG-3'.

No. 6 nt 1250–1269: 5'-CGTCCAATGTTCAGGATTAG-3'.

No. 7: nt 1045–1062: 5'-AGATGTCGAGTTAAAGATCC-3'.

No. 8: nt 1135–1154: 5'-ACTCGTTGATAAAACTCTCC-3'.

No. 9: nt 1–25: 5'-ATCCGTTCTTATGGCAGGTGATCTG-3'.

No. 10: nt 1561–1585: 5'-TGGCGAATGAGTGTGTGTGGATCAG-3'.

No. 11: nt 1079–1102: 5'AGTGTTTTAGCTGGCCAGAGCCTCT-3'.

No. 12: nt 1217–1241: 5'ATTGATGGCTACCGGGTGGCAAAGG-3'.

No. 13: nt 142–161: 5'-GGTATGGGACAGAAAGACAG-3'.

No. 14: nt 452–471: 5'-AGAGTCCATCACGATACCAG-3'.

No. 15: nt 345–369: 5'-GGCCAACAGGGAAAAGATGACACAG-3'.

RT-PCR cloning of zebrafish P450arom cDNAs
cDNA was synthesized from 5 µg total RNA from adult brain and ovary using oligo(dT) primers and SuperScript II reverse transcriptase (Life Technologies, Inc., Gaithersburg, MD) according to the manufacturer’s instructions. An aliquot (10%) of the first-strand reaction was amplified with degenerate primers nos. 1 and 2 using a DNA Thermal Cycler 480 (PE Applied Biosystems, Foster City, CA). PCR was performed in 50-µl final volume containing 5 µl 10x reaction buffer, 2 µM MgCl2, 200 µM deoxynucleotide triphosphate, 2 µM of each primer, and 2.5 U Taq DNA Polymerase (Promega Corp.). The reaction mixture was heated at 94 C for 5 min, then amplified for the first 5 cycles as follows: 1 min denaturing at 94 C, 2 min annealing at 37 C, and 3 min extension at 72 C. The remaining 30 cycles were carried out similarly except for an annealing temperature of 50 C instead of 37 C. The amplified products were separated on a 2% agarose gel, isolated from the gel using GLASSMILK (GENE-CLEAN III kit; BIO 101, Vista, CA), and an aliquot (20%) of each was used as a template for reamplification exactly as described above. The reamplified products were purified and T-A cloned into pGEM-T Easy vector (Promega Corp.).

The 5' and 3' ends of the brain-derived P450aromB cDNA were obtained by rapid amplification of cDNA ends (RACE) using the Marathon cDNA Amplification kit (CLONTECH Laboratories, Inc., Palo Alto, CA), and gene-specific primers nos. 3 (3' RACE) and 4 (5' RACE). The amplification of adaptor-ligated, oligo(dT)-primed double-stranded brain cDNA was done with Advantage cDNA polymerase mix containing a proof-reading polymerase (CLONTECH Laboratories, Inc.) and a touch-down program: denaturing at 94 C for 1 min followed by 5 cycles of 94 C for 30 sec, and 72 C for 4 min, 5 cycles of 94 C for 30 sec, and 70 C for 4 min, and 25 cycles of 94 C for 20 sec, and 68 C for 4 min. During the course of these experiments, an unpublished zebrafish ovary-derived P450arom sequence was deposited in the GenBank database by Bauer and Goetz (accession number AF004521). Because the sequence of our initial P450aromA cDNA fragment had 97% identity when compared with the GenBank sequence, the remaining coding sequence was obtained by end-to-end PCR using primers nos. 9 and 10, which corresponded to nucleotides in the 5' and 3'-untranslated (UTR) regions of the reported sequence. Amplification of double-stranded oligo (dT)-primed ovarian cDNA was performed under the same conditions used to obtain the initial cDNA fragments except that the high fidelity Advantage cDNA polymerase mix (CLONTECH Laboratories, Inc.) was substituted and amplification was done by denaturing at 94 C for 5 min followed by 30 cycles of 94 C for 30 sec, 60 C for 30 sec, and 72 C for 4 min.

Sequencing and computer analysis
Sequencing of cDNA was done on both strands of double-stranded DNA using the BigDye Terminator Cycle Sequencing Ready Reaction (PE Applied Biosystems) and an automated sequencer (ABI PRISM 377 DNA Sequencer, PE Applied Biosystems). The complete sequences were obtained using Sp6, T7, PucM13 forward, and PucM13 reverse primers (Promega Corp.), which were complementary to the vector, and sequential internal primers. The nucleotide and deduced amino acid sequences were analyzed using the WI Package Version 9.0, Genetics Computer Group (GCG) (Madison, WI). For phylogenetic analysis the deduced amino acid sequences of zebrafish brain- and ovary-derived P450arom, together with P450arom sequences reported for other vertebrate species, were aligned by CLUSTAL W, version 1.6 (19). The aligned sequences were used to construct phylogenetic trees by distance (Neighbor-Joining algorithm) and maximum parsimony criteria PAUP (Phylogenetic Analysis Using Parsimony, version 4.0, b2) (20). Only regions without length variations (393 conserved characters of 544 total) were used to construct phylogenetic trees. Trees were drawn with shark P450arom (ovary-derived) as an outgroup (Wang, C., M. Betka, and G. V. Callard, unpublished; GenBank accession number AF203106). Deduced amino acid sequences also were analyzed by Motif on the GenomeNet (The Supercomputer Laboratory, The Institute for Chemical Research, Kyoto University, Kyoto, Japan).

Northern analysis
Total RNAs (20 µg) from adult brain, ovary, liver, and testis were size-separated on a 1% formaldehyde agarose gel and transferred to a nylon membrane (BrightStar-Plus; Ambion, Inc.). The hybridization probe used to detect P450aromB mRNA was a 1.5 kb 5'-RACE cDNA (nt 1–1367, see Fig. 2Go) and random primed with [{alpha}-32P]ATP using the Strip-EZ DNA kit (Ambion, Inc.) according to the manufacturer’s protocol. Hybridization was performed using the Northern Max Plus kit (Ambion, Inc.) at 64 C for 2 h and a probe concentration of 1 x 106 cpm/ml. The final stringent wash was 0.1 x SSC, 0.1% SDS before exposure to film (BioMax MR; Kodak, Rochester, NY). The membrane was stripped according to the manufacturer’s protocol and rehybridized with a 247-base P450aromA complementary RNA derived from the corresponding cDNA fragment (nt 1104–1350). The plasmid was linearized with SalI, transcribed, and labeled with [{alpha}32P]UTP using the Strip-EZ RNA kit (Ambion, Inc.). The membrane was hybridized in ULTRAhyb (Ambion, Inc.) containing 1 x 106 cpm/ml overnight at 68 C. The final stringent wash was 0.1x SSC and 0.1% SDS. To control for RNA loading, the membrane was rehybridized with a 330-base zebrafish ß-actin complementary RNA, which was transcribed from a cloned cDNA obtained by RT-PCR using liver RNA and primers nos. 13 and 14. Transcript sizes were estimated using an RNA ladder (Life Technologies, Inc.).



View larger version (28K):
[in this window]
[in a new window]
 
Figure 2. Phylogenetic tree of P450arom proteins. The tree was constructed by maximum parsimony using the BRANCH AND BOUND option of PAUP and represents a consensus of four similar trees. The same topology was obtained using the Neighbor-Joining approach. Deduced amino acid sequences of P450arom forms were used from zebrafish brain (AF226619) and ovary (AF226620); goldfish brain (AAB39408) and ovary (AAC14013); medaka ovary (BAA11657); trout ovary (228574); catfish ovary (AAB32613); chicken ovary (AAA48738); human ovary/placenta (AAA52132) (for references, see legend to Fig. 1Go). Additional sequences (and GenBank accession numbers) were from zebrafinch ovary (AAB32404); mouse ovary (BAA00551); rat ovary (AAA41044); bovine ovary/placenta (AAA62244); and pig blastocyst (AAAB51388). P450arom derived from shark ovary (unpublished, AF203106) was designated as the outgroup taxon.

 
RT-PCR and Southern transfer
Total RNA (5 µg) from adult tissues or staged embryos was reverse transcribed as described above. PCR was performed with 2 µl (10%) of the RT reaction and two gene-specific primer sets simultaneously or separately, as specified: oligonucleotides Nos. 5 and 6 for P450aromB and nos. 7 and 8 for P450aromA (0.2–0.4 µM each). The primer pairs were designed to overlap putative exon-exon junctions, thereby avoiding amplification of any contaminating genomic DNA, and to generate products that differed in length (210- and 110-bp for P450aromB and A, respectively) but had a similar amplification efficiency. The specificity of the primer sets was tested separately and together using brain and ovarian RNA and the respective authentic cloned P450arom cDNAs. For each experiment, cycle number was varied in a pilot study to optimize yield and approximate linearity for the P4540aromB product (the P450aromA product was always lower than P450aromB as determined by ethidium bromide staining). ß-Actin was amplified using a separate but equivalent aliquot of the same RT reactions and primers nos. 13 and 14 (0.04–0.2 µM each; 330-bp product size). Other components of the PCR mix were as described above. The reaction mixture was first denatured for 5 min at 94 C, then 30–34 cycles of amplification were performed (30 sec denaturing at 94 C, 30 sec annealing at 58 C, 1 min extension at 72 C) with a final extension at 72 C for 10 min. An aliquot (5–40 µl) of the reaction was analyzed on a 2% agarose gel containing ethidium bromide. To verify authenticity of amplification products and independently estimate quantitative differences, gel products were transferred to a nylon membrane (Magna Charge; MSI, Westboro, MA), and the membrane was sequentially hybridized with oligonucleotides nos. 11 and 12 (complementary to P450aromA and–B, respectively) or with nos. 15 (complementary to ß-actin). Oligonucleotides were end-labeled with [{gamma}-32P]ATP (DuPont/NEN Life Science Products, Boston, MA) and T4 polynucleotide kinase (Promega Corp.) according to the manufacturer’s protocol. Hybridization was carried out overnight at 60 C in hybridization solution (5x SSC, 0.1% SDS, and 100 µg/ml sheared salmon sperm DNA, Ambion, Inc.) containing 1 x 106 cpm/ml radiolabeled oligonucleotide. After each hybridization, the membrane was washed, 5 min each, in 6x SSC and 6x SSC/0.1% SDS at room temperature and then exposed to film for 3–24 h. Between hybridizations, the membrane was stripped in 0.1x SSC/0.5% SDS at 95 C. The autoradiographs were scanned using Adobe Photoshop software, and the integrated density of each amplified fragment was determined from the digital image using Scion Image software based on NIH Image, version ß3b (Scion Corp., Frederick, MD).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Isolation of two zebrafish P450arom cDNAs
P450aromB (AF226619). A 3.8-kb cDNA encoding P450aromB was isolated by RT-PCR from zebrafish brain. Initially, a fragment of approximately 450-bp was amplified using a degenerate primer pair (oligonucleotides nos. 1 and 2). By means of RACE with primers nos. 3 and 4 (complementary to sequence in the initial 450-bp fragments), 5'- and 3'-RACE products of approximately 1.4 and 2.8-kb, respectively, were isolated. Five 5'-RACE clones were sequenced, and two were identical. Although there were thirteen nucleotide substitutions in the open reading frame (ORF) among these 5 clones (A79T, C256T, T283C, T316C, C448A, A458G, C521T, T544C, C592T, C1102T, T1111G, T1211C, G1269A), these differences did not result in amino acid substitutions and may be due to PCR errors. Four 3'-RACE clones were sequenced. There were no nucleotide substitutions in the ORF of these four clones, but 6.5% of substitutions or deletions in the UTRs. The deduced amino acid sequence derived from the zebrafish P450aromB cDNA is based on an ORF of 1533-bp which starts at an ATG codon at nt 74 and continues to a stop codon TAA (nt 1607). This ORF encoded a protein of 511 amino acids with a calculated molecular mass of 58.1 kDa (Fig. 1Go). Although a second ATG was located immediately downstream from the first (nt 77), only the first had a nucleotide context (GAGGTGATGA) similar to the proposed consensus sequence for initiation (21). A third, in-frame ATG was located upstream of the first two at nt 41 but was discounted as an initiation site due to an intervening stop codon at nt 47. The 5' UTR of the zP450aromB cDNA was 73 bp long, a little shorter than the 5' UTR of the goldfish P450aromB cDNA (109 bp) obtained by library screening (12), but much longer than the reported sequence of the catfish and tilapia P450aromA cDNAs (20 and 33 bp, respectively) (22, 23). The 3' UTR of the zP450aromB was 2208 bp in length and contained three polyadenylation signals.



View larger version (117K):
[in this window]
[in a new window]
 
Figure 1. Alignment of P450arom amino acid sequences. Clustal W multiple sequence alignment (version 1.6) (19 ) was used to compare the zebrafish P450aromB and P450aromA with P450arom forms derived from goldfish brain (12 ) and ovary (10 ); medaka ovary (24 ), trout ovary (25 ), catfish ovary (22 ), tilapia ovary (23 ), chicken ovary (26 ), and human placenta (27 ). Regions of high sequence homology are boxed and indicated by Roman numerals: I-helix (I); aromatase-specific conserved region (II); and heme-binding region (III) (2 ). Identical and similar amino acid residues are marked by asterisks and dots, respectively. Arrowheads indicate location of exon-intron boundaries in human and medaka genes (for review, see Ref. 51 ). Marked in boldface type in the two fish brain-derived P450aromB forms are identical residues that differ from amino acids that are conserved in all fish ovary-derived (and some avian and mammalian) aromatases. Protein kinase C phosphorylation (PKC) sites at residues 118, 168, and 469, and casein kinase II phosphorylation (CKII) sites at 291 and 325 (based on the zebrafish B-isoform) are distinct to B-isoforms. A PKC site at position 392 and CKII site at; 190 (based on the zebrafish A-isoform) are distinct to most fish A-isoforms. N-glycosylation sites at position 43 of the zebrafish B-isoform and 30 of the zebrafish A-isoform, and PKC sites at 113, 199, and 362 (based on the zebrafish B-isoform) are conserved in all or most aromatases. See legend to Fig. 2Go for GenBank accession numbers of the sequences used.

 
P450aromA (AF226620). A 1.6-kb cDNA encoding P450aromA was isolated by RT-PCR from zebrafish ovary. An initial 450-bp fragment was amplified from ovarian RNA using the degenerate primer pair (oligonucleotides nos. 1 and 2). Five clones were sequenced, and the deduced amino acid sequences of two were similar to identified fish, avian, and mammalian aromatases (10, 12). A cDNA containing a complete ORF was obtained using oligonucleotides nos. 9 and 10, which targeted regions in 5' and 3' UTRs of the Bauer and Goetz sequence. Three approximately 1.6-kb cDNA clones were sequenced, and two were identical. The third clone had three nt substitutions (G796A, G805A, A1501G), but these did not alter amino acid sequence. When our P450aromA cDNA was compared with that of Bauer and Goetz, there were 11 nucleotide substitutions (G646A, C779T, A795G, G796A, G805A, T870C, C886T, T9928C, T1444C, A1501G, C1538T). Only one of them (C1538T) resulted in a nonconservative change: Q in this study, reported as a stop codon in the Bauer and Goetz sequence. The position of the stop codon of our P450aromA corresponded to that of the goldfish P450aromA (10). The deduced amino acid sequence of the zebrafish P450aromA was derived from an ORF of 1551-bp, which starts at the first ATG (nt 11) and continues to the stop codon TGA (nt 1562). The ORF encoded a protein of 517 amino acids with a calculated molecular mass of 58.3 kDa (Fig. 1Go). Similar to the other reported fish ovarian aromatases (goldfish, 10; medaka, 24; tilapia, 23; trout, 25; catfish, 22), the zebrafish P450aromA had a second potential initiation site 30-bp downstream from the first, but neither of the two ATGs had a nucleotide context that matched the proposed consensus sequence for initiation of translation. The zebrafish P450aromB had a shortened N terminus and an extended carboxy terminus relative to the P450aromA isoform, features that distinguish the two goldfish P450arom forms (10, 12).

Sequence comparisons
Figure 1Go shows the deduced amino acid sequence of the two zebrafish aromatases aligned with P450arom forms of representative other vertebrates: goldfish ovary (10); goldfish brain (12); medaka ovary (24); tilapia ovary (23); trout ovary (25); catfish ovary (22); chicken ovary (26); human placenta (27). The two zebrafish aromatases shared only 61% overall sequence identity, but each isoform was 88% identical with the corresponding B- or A-isoform of goldfish. When compared with catfish, medaka, tilapia, and trout aromatases (all ovary-derived), the zebrafish P450aromA was more closely related (64–73% identity) than P450aromB (58–62% identity). The two zebrafish isoforms had similar degrees of relatedness to chicken and human aromatases (52–54%), but the degree of conservation was higher in the putative functional domains, including the I-helix (65–71% vs. chicken and human), the aromatase-specific region (83–87% vs. chicken and human), and the heme-binding region (79–71% vs. chicken and human), and was lowest at the termini of the different forms. Based on mutational analysis and molecular modeling, amino acids known to be essential for catalytic functions in the human P450arom (I133, E302, P308, D309, T310, R435, C437; for review, Ref. 28) were identical in both zebrafish forms.

Where the zebrafish aromatases overlap, there were a total of 194 amino acid differences, of which 54% were nonconservative substitutions. Many of the differences were clustered at the N terminus and in the central part of the molecule, including regions of putative exons 5, 6, and 8, and the N terminus of exon 1, indicating that the two aromatases, like their goldfish counterparts, are more likely to be derived from different genes than from alternative exon splicing. Also, sequences within the two isolated cDNAs have been identified by PCR in zebrafish genomic DNA (29). Some substitutions distinguish the zebrafish B-isoform from conserved residues in all fish ovarian or all nonneural forms, including chicken and human (Fig. 1Go). These were located in putative functional domains: I-helix (D293E and D294N) and the aromatase-specific conserved region (L393I) (based on numbering of the zebrafish P450aromB). Of these, the first two were conservative substitutions. Also, a histidine residue at position 128 of the human P450arom, which may be involved in orientation of the substrate in the active site (28), corresponded to a histidine in both goldfish and zebrafish P450aromA, but a phenylalanine in the two fish P450aromB forms. Further analysis with the Motif program revealed consensus sequences that are common to all or most aromatases, and other sites that are B- or A-isoform specific, an indication that these sites have possible functional importance (see legend, Fig. 1Go).

Phylogenetic analysis
Phylogenetic analysis of the full-length zebrafish P450aromB and P450aromA sequences together with other published full-length P450arom sequences (including only regions without length variations) yielded four most parsimonious trees. Figure 2Go shows the strict consensus tree of these four trees (CI = 0.863). P450aromB isoforms from zebrafish and goldfish formed a group (clade) that branched separately from a second clade that included the zebrafish and goldfish P450aromA together with all other teleostean P450arom forms (all ovary-derived). Mammalian and avian P450arom sequences formed a third distinct group (although no brain-derived P450arom-encoding cDNAs have been reported to date). The unpublished shark ovarian P450arom was the designated outgroup. The topology of this tree was similar to that obtained by distance analysis (Neighbor-Joining algorithm; not shown) and is consistent with duplication of an ancestral gene early in the teleostean lineage, resulting in the fish P450aromB and -A paralogs.

Tissue-specific expression
Northern blot analysis of zebrafish total RNA was carried out to determine the size and number of P450aromB and P450aromA mRNAs (Fig. 3Go). A single 4.4-kb transcript was identified in brain using a 1.36-kb cDNA probe derived from the isolated P450aromB cDNA, but no signal of any size was detectable in ovary, testis, or liver. Rehybridization of the membrane with cDNA probes from different regions of the P450aromA sequence failed to detect a signal even after long exposures, indicating a lower level of expression than the P450aromB isoform. However, hybridization with a P450aromA riboprobe (247 bases in length) followed by a 30-day exposure revealed a single major transcript of approximately 2.1-kb in ovary. No P450aromA-specific mRNA was detected in brain, testis, or liver, but the same probe nonspecifically labeled 28 S ribosomal RNA in all lanes. Both P450aromB and P450aromA transcripts were larger than the PCR-derived cDNAs: respectively, 4.4 vs. 3.8 kb and 2.1 vs. 1.6 kb.



View larger version (57K):
[in this window]
[in a new window]
 
Figure 3. Northern blot analysis of zebrafish P450romB and P450aromA RNA. Total RNA (20 µg) from brain (Br), ovary (O), liver (L), and testis (T) was hybridized sequentially with a [32P]-labeled P450aromB cDNA (4-day exposure), a [32P]-labeled P450aromA riboprobe (30 days exposure), and a [32P]-labeled ß-actinriboprobe (7 h exposure). Transcript sizes and positions relative to 28S ribosomal RNA are shown on the left of each panel.

 
RT-PCR followed by Southern transfer analysis confirmed differential expression of P450aromB and -A in adult zebrafish brain and ovary (Fig. 4Go). The two primer sets generated products of different length when used in the same or different amplification reactions (210-bp for P450aromB and 110-bp for P450aromA) but amplification efficiencies of P450arom plasmids were similar. Likewise, the 32P-labeled oligonucleotide hybridization probes targeted internal sequences specific to the P450aromB or P450aromA products. P450aromB mRNA was highest in the brain, whereas P450aromA mRNA was highest in ovary. Both P450arom forms were expressed in the eye (which includes retina, a site of P450arom enzyme and mRNA expression in goldfish; 7, 10). Notably, faint bands were seen in the ovary lane after hybridization with the P450aromB probe, and in the brain lane after hybridization with the P450aromA probe, indicating a low level of overlapping expression. Neither P450aromB nor P450aromA mRNA was detectable in adult liver, testis, or muscle



View larger version (93K):
[in this window]
[in a new window]
 
Figure 4. Tissue-specific distribution of P450aromB and A mRNA in adult zebrafish as determined by RT-PCR analysis and Southern transfer. Total RNA (5 µg) from zebrafish brain (Br), ovary (O), eye (E, including retina), liver (L), testis (T), and muscle (M) was reverse transcribed with oligo(d)T primers. Control (no template, H2O). Primer sets specific for sequences in P450aromB and P450aromA were used simultaneously in the same reaction to obtain 210- and 110-bp products, respectively (top panel, ethidium bromide-stained gel), and ß-actin-specific primers were used with a separate, but equivalent, aliquot of the same RT reactions. An aliquot of each PCR sample was size separated by agarose gel electrophoresis and ethidium bromide stained (top panel). Following transfer and hybridization with internal gene-specific [32P]-labeled oligonucleotides, membranes were exposed for 30 min (P450aromB, second panel), 1 h (P450aromA, third panel), and 2 h (ß-actin, bottom panel). Results were similar with a second adult tissue series.

 
Expression of P450aromB and -A mRNA during early development
Figure 5AGo shows the onset and temporal pattern of expression of P450aromB and P450aromA in unfertilized eggs and whole embryos as measured by RT-PCR/Southern analysis. Developmental profiles are also plotted after scanning, with the band areas at 1.5 hpf for each cDNA product series designated as the arbitrary reference point (1.0) (Fig. 5BGo). Although RT-PCR/Southern analysis is at best semiquantitative, comparison of ethidium bromide stained bands and hybridization signals show clear stage- and isoform-related differences. Both P450aromB and P450aromA specific mRNAs were detectable in unfertilized eggs and at the first time point in embryogenesis (1.5 hpf; 16 cell stage), but signal intensity declined progressively at 6 and 12 hpf. This pattern is consistent with transfer and degradation of maternally transcribed mRNA. Despite a lower initial band intensity relative to the A-isoform, the P450aromB product was less rapidly degraded. A secondary rise in both isoforms was seen between 12 and 24 hpf, indicative of the onset of embryonic transcription; thereafter, stage-related patterns differed. An abrupt and dramatic approximately 11-fold increase in relative signal intensity of P450aromB mRNA occurred between 24 and 48 hpf, and by 120 hpf (early larval period) the signal was about 25-fold higher than at 24 hpf. Relative signal intensity of P450aromA mRNA increased more gradually than that of P450aromB and the difference between 24 and 120 hpf was 7-fold. Note that the P450aromB product gives a more intense ethidium bromide signal than P450aromA product band at each stage of development. Also, although the P450aromA product was much greater than the B-product immediately after fertilization (1.5 hpf), consistent with the predominant ovarian A-isoform in adult fish, P450aromB signal intensity greatly exceeded that of P450aromA in free swimming larvae (120 hpf), consistent with the high level of P450aromB expression in adult fish (compare Fig. 5Go to Figs. 3Go and 4Go). In contrast to progressive increases in relative P450arom levels during the first 120 h of development, the two mRNA species changed little or declined between 1 and 3 weeks of age (Fig. 6Go), possibly due to changes in the proportion of P450arom-expressing and nonexpressing tissues in the growing larvae. Although results shown are based on total RNA equivalents (equal loading), developmental profiles were similar (but even greater in magnitude) if expressed on a per embryo basis (see legend to Fig. 5Go).



View larger version (47K):
[in this window]
[in a new window]
 
Figure 5. Stage-related expression of P450aromB and A in unfertilized eggs and during early development as determined by RT-PCR and Southern transfer analysis. Unfertilized eggs (0 hpf) were obtained by stripping a gravid female. Embryos were a different cohort obtained after natural spawning (1.5–120 hpf). A, See legend to Fig. 4Go. Exposures for P450aromB were 2 h (eggs) and 12 h (embryos); for P450aromA, 1 h (eggs) and 10 h (embryos); and forß-actin, 3 h (eggs and embryos). (B) For the embryo series, the integrated density of each amplified fragment was determined from the digital image of the autoradiographs. For each mRNA subtype, the signal at 1.5 hpf was arbitrarily set at 1.0 to obtain the other values. Results shown are based on equal loading of total RNA. The number of embryo/larva equivalents per lane was 1.06 (1.5 hpf); 0.89 (6 hpf); 0.92 (12 hpf); 0.50 (24 hpf); 0.57 (48 hpf); 0.29 (72 hpf); and 0.22 (96 and 120 hpf). This experiment is representative of four separate staged embryo series.

 


View larger version (41K):
[in this window]
[in a new window]
 
Figure 6. Differential effects of estrogen on P450aromB and P450aromA expression during embryogenesis as measured by RT-PCR and Southern transfer analysis: onset and persistence of the response. A, Exp. 1. Embryos were treated with E2 (1.0 µM) beginning at 2 hpf and P450aromB and P450aromA mRNAs were measured at 24 or 48 hpf. Exposures were 10 min (P450aromB), 45 min (P450aromA), and 30 min (actin). B, Exp. 2. Embryos were treated with E2 (1.0 µM) between 2 and 72 hpf, washed, and allowed to continue development in steroid-free conditions to 1, 2, or 3 weeks of age. Also see legend to Fig. 4Go. Results were similar in five separate experiments. Exposures were 1.5 h (P450aromB), 5 h (P450aromA), and 30 min (actin).

 
Differential effects of estrogen on P450aromB and P450aromA during development
The presence of E2 (1 µM) in embryonic culture media during the first 24, 48, or 72 hpf (Fig. 6AGo, Exp. 1; Fig. 6BGo, Exp. 2) amplified and advanced the developmentally programmed increase in P450aromB band intensity when compared with stage-matched controls. The stimulatory effect of E2 treatment between 2 and 48 hpf (not shown), or between 2 and 72 hpf (Fig. 6BGo), persisted for 2 weeks after washout but was no longer discernible after 3 weeks. The ER antagonist ICI.164.384 alone decreased P450aromB band intensity and the effect was reversed by simultaneous addition of E2, implying blockade of an endogenous estrogen/ER-mediated component of P450aromB expression. In contrast to P450aromB, signal intensity of P450aromA was lower (Fig. 6Go, A and B) or unchanged after E2 treatment (Fig. 7Go, one of three experiments). Note that the fold-increase in P450aromB band intensity with E2 exposure in some experiments (e.g. Fig. 7Go) was more modest than in other experiments (e.g. Fig. 6Go), which could be explained by differences in the degree of developmental synchrony in different cohorts (unpublished observations).



View larger version (79K):
[in this window]
[in a new window]
 
Figure 7. Differential effects of estradiol-l7ß and estrogen receptor antagonist on P450aromB and P450aromA mRNAs during embryogenesis as measured by RT-PCR and Southern transfer analysis. Embryos were treated between 2 and 48 hpf at the concentrations shown: C, control (vehicle only); E2, estradiol (1 µM); ICI, ICI164.384 (1 or 10 µM); H2O, no DNA. Exposures were 4 h (P450aromB), 4 h (P450aromA), and 3 h (actin). Results were similar in three separate experiments.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Evidence to date indicates that the gene encoding P450arom in humans is a single member of the cyp19 family (2), but multiple cyp19 loci and isoforms, each with a different tissue-specific and developmental program have been identified in pig blastocyst, ovary and placenta (30, 31). Recently, we reported that the goldfish has at least two cyp19 loci, which encode structurally and functionally distinct P450arom isozymes in brain and ovary: respectively, cyp19b/P450aromB and cyp19a/P450aromA (10 ; Zhao, J., P. Mak, A. Tchoudakova, G. V. Callard, and S. Chen, unpublished data). Because the zebrafish has many advantages as a model for establishing a relationship between a gene and its functions, we have isolated and characterized the zebrafish counterparts of the two goldfish aromatases. Sequence comparisons and phylogenetic analysis indicate that the fish brain- and ovary-derived P450arom forms are orthologs of the previously identified mammalian and avian aromatases and members of paralogous clades within the fish lineage. In contrast to the pig isoforms which share 87–93% sequence (30, 31), the B- and A-isoforms of fish are only about 61% identical, indicating a long evolutionary history as separate genes.

Present day fish have multiple loci for many single-copy mammalian genes, which is presumed to be the consequence of a genome duplication event in an early fish ancestor. One mechanism for preservation of gene duplicates is the subdivision of ancestral expression domains by complementary degenerative mutations in their regulatory regions (32). In support of this theory, Northern analysis in goldfish (10) and zebrafish shows that expression of P450aromB is restricted to brain, which has high levels of mRNA and enzyme activity, whereas P450aromA is expressed exclusively in ovary which has relatively low mRNA and activity. RT-PCR confirms differential expression in neural and nonneural tissues but also reveals a degree of overlap, which cannot be discounted as an evolutionary remnant. For example, although the B-isoform predominates in both brain and retina, the relative abundance of the A-isoform differs, which could be due to differential regulation of a single cell population or to differences in the relative numbers of isoform-specific cell types. Likewise, although only trace amounts of P450aromB are detected in adult fish ovary, the B isoform is higher relative to the predominant A isoform in unfertilized and newly fertilized eggs.

In diverse animal species, maternally inherited mRNAs and proteins are used to program the earliest stages of development but are degraded by the midblastula transition, allowing genetic control of development to pass to zygotically synthesized transcripts (33). The presence and temporal patterns of P450aromB- and -A mRNAs in unfertilized eggs and embryos (1.5–12 hpf) are consistent with maternal transfer and degradation. A possible source of maternally derived P450arom mRNAs is transcription by maturing or preovulatory oocytes. Although fish granulosa cells have high steady-state levels of P450arom mRNA (A-subtype) (23, 25), localization in oocytes has not been noted, nor has the B-isoform been characterized or used for mRNA analysis in these studies. Aromatase mRNA has been detected in some samples of isolated rat oocytes using a sensitive RT-PCR assay, but results were discounted as being due to contaminating somatic cells (34). Although we cannot rule out the possibility that residual follicle cells account for a fraction of the measured mRNAs in unfertilized zebrafish eggs, which were obtained by stripping, this explanation is unlikely to apply to early embryos, which were collected after natural spawning. An alternative possibility is that mRNAs transcribed in granulosa cells are transferred to oocytes by way of gap junction-like complexes that are present before ovulation or after hCG-induced follicle maturation in several fish species (35). It may be relevant here that a novel P450arom promoter switching event from the ovary-specific promoter II to the brain-specific promoter 1F is associated with HCG-induced ovulation in equine granulosa cells (36). A mechanism of this type, if present in zebrafish, would explain the presence of both A and B isoforms in adult ovary and reinforce the idea that follicle-oocyte transfer accounts for maternally derived aromatase mRNAs in eggs and early embryos. Interestingly, P450aromB degrades more slowly than P450aromA mRNA (1.5 vs. 6 hpf), which may be related to its larger size when compared with the ovarian transcript (4.4. vs. 2.1 kb, respectively). Because differential stabilization of transcripts in specific regions of the cytoplasm is one of several RNA localization mechanisms that play a role in patterning and cell-fate decisions (37), it will be important to determine the spatial arrangement of each P450arom species during the earliest stages of development and to determine whether P450arom transcripts are among the maternal mRNAs that are not specifically blocked from translation (33).

In zebrafish, transcription of the zygotic genome begins at about 3 hpf (38). Shortly thereafter, the onset of transcription of the two cyp19 genes is detectable as an increase in P450arom mRNAs (12–24 hpf; segmentation period). The segmentation period in zebrafish is characterized by major expansion, morphogenesis, and cellular differentiation of the developing CNS: e.g. the neural plate is sculpted into the three major brain divisions and primary neurons are first identifiable (13). At the same time, primordial germ cells complete their migration to their final destination in the lateral mesoderm where they form two clusters ventral to somites 3–5 (39). Consistent with continued expansion and development of the CNS and gonads, P450aromB and P450aromA mRNAs accumulate progressively through embryogenesis and the early larval period (24–120 hpf), but isoform-specific differences in relative abundance and temporal patterns are evident. P450aromB mRNA is characterized by an abrupt and dramatic 11-fold increase between 24 and 48 hpf and continues accumulating to a level about 15-fold higher by 120 hpf. The rise in P450aromA mRNA is more gradual, and at 120 hpf is 7-fold higher than at 24 hpf. We have not yet determined whether expression of the two P450arom isoforms in embryos is predominantly neural and gonadal, as in adult zebrafish, or whether there is an extraembryonic origin (e.g. yolk syncitial layer), as in mammals. However, a preliminary study shows that microinjection of fertilized eggs with a green fluorescent protein (GFP) construct driven by the goldfish cyp19b promoter results in labeling of neuron-like cells in the forebrain of 30–48 hpf embryos, a timing that is consistent with RT-PCR of endogenous mRNA (Tchoudakova, A., M. Kishida, E. Wood, and G. V. Callard, unpublished data). No labeling was seen after injection of the cyp19a-driven reporter, which could be due to lower expressed levels. The onset of P450arom mRNA and enzyme is at 6 days post coitus in porcine and equine blastocyts (40, 41). In these species, aromatase is localized mainly in extraembryonic trophectoderm, but a few labeled cells are identifiable in hypoblast, a subembryonic layer of primitive endoderm and the route of migration of primordial germ cells (42). The earliest onset of aromatase mRNA in dissected whole brain or diencephalon is at 14 days gestation in rats (43), 11 days gestation in mice (44), and stage 13 (approximately 10 days at 31 C in ovo) in turtles (45), whereas the earliest measured gonadal aromatase mRNA is at 17 days gestation in mice (46) and 50–55 days post hatching in flounder and trout (47, 48), and at stage 18 (approximately 21 days at 31 C in ovo) in adrenal/kidney/gonadal complex in turtles (45).

In this report, we present evidence that mechanisms regulating high constitutive expression and estrogen mediated up-regulation of P450aromB in the brain of adult fish are already operative in 24–48 hpf zebrafish embryos. In response to estrogen, the increase in B-specific mRNA in zebrafish embryos is 5- to 10-fold, depending on the duration of exposure (1–3 days), which is similar in magnitude to seasonal and estrogen-mediated changes in adult goldfish (12). Surprisingly, the estrogen effect persists in larvae up to 2 weeks after washout, which might be explained by sequestration of administered estrogen in yolk (16). Yolk is reported to contain substantial amounts of maternally derived estrogen and aromatizable androgen (17). Estrogen taken up directly from yolk, or in situ synthesis, would explain why ICI164.384 (an ER antagonist) is able to block a component of the developmentally programmed increase in P450aromB mRNA. Although radiolabeled tracer analysis is not sufficiently sensitive to detect estrogen biosynthesis in 72 hpf zebrafish embryos, addition of testosterone to embryo media between 2 and 48 hpf mimics estrogen-induced up-regulation of P450aromB (Kishida, M., unpublished data), implying that mRNA present in the embryo is translated into functional enzyme. In support of this conclusion, aromatase activity has been detected by tracer analysis in embryos and larvae of steelhead trout (22–30 dpf) (17) and Arctic char (28–62 dpf) (18). Whereas brain aromatase in fish and birds is induced by estrogen, brain aromatase expression in adult rats is up-regulated by androgen (4). It is noteworthy, however, that treatment of perinatal female rats with aromatizable androgen enhances the subsequent expression and androgen responsiveness of aromatase in the adult brain (49).

The early onset of P450arom expression in zebrafish embryos, and differences in the developmental programming and estrogen responsiveness of B- and A-isoforms, imply that estrogen probably has multiple roles in development. It is well established that estrogen synthesized by the mammalian preimplantation blastocyst, or secreted by the maternal ovary, is essential for the successful establishment of pregnancy. Although the adult female reproductive tract is viewed as the main target of early estrogen action, ER mRNA has been identified by RT-PCR in mouse oocytes and fertilized eggs and, after a period of decline, reappears at the blastocyst stage (50). We have identified three distinct ER subtypes (termed ER{alpha}, ß and {gamma}) in adult zebrafish liver by PCR cloning, and RT-PCR analysis of embryos reveals a developmental profile similar to that in the mouse (Akten, B., M. Kishida, and G. V. Callard, unpublished data). This is consistent with the onset of estrogen responsiveness, as measured by up-regulation of P450aromB at 24–48 hpf. Taken together, these and earlier observations (for review, see Ref. 50) support the conclusion that the embryo itself is a target of estrogen action.

Because zebrafish are genetically manipulable and have many advantages for studying development (e.g. transparent embryos, numerous identified mutants), they are an excellent model system for investigating estrogen’s role as a developmental hormone. Moreover, the presence of two cyp19 genes with subdivided expression domains and distinct regulatory mechanisms should facilitate recognition of brain- and gonad-specific processes, even in the earliest stages of embryogenesis, and in future will allow clear cause-and-effect relationships to be established by gene-specific manipulation strategies.


    Acknowledgments
 
The authors would like to thank Dr. Beverly Keniston and Debra Smith for maintenance of zebrafish colonies, Dr. Mark E. Hahn and Bikem Akten for their help with phylogenetic analyses, and Dr. Anna Tchoudakova for supplying degenerate primers and helpful discussions during the course of the study.


    Footnotes
 
1 This research was supported by grants from the National Science Foundation (IBN-96-05053) and the NIH (P42 ES-07381). The nucleotide sequences reported in this paper have been submitted to the GenBank/EMBL Data Bank with accession numbers AF226619 and AF226620. Back

Received June 15, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. McEwen BS 1994 Steroid hormone effects on brain: novel insights connecting cellular and molecular features of brain cells to behavior. Methods Neurosci 22:525–542
  2. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD, Mendelson CR, Bulun SE 1994 Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 15:342–355[Abstract/Free Full Text]
  3. Naftolin F, Ryan KJ, Davies IJ, Reddy VV, Flores F, Petro Z, Kuhn M, White RJ, Takaoka Y, Wolin L 1975 The formation of estrogens by central neuroendocrine tissues. Recent Prog Horm Res 31:295–319
  4. Lephart ED 1997 Molecular aspects of brain aromatase cytochrome P450. J Steroid Biochem Mol Biol 61:375–380[CrossRef][Medline]
  5. Williams CL 1998 Estrogen effects on cognition across the lifespan. Horm Behav 34:80–84[CrossRef][Medline]
  6. Pasmanik M, Callard GV 1988 Changes in brain aromatase and 5 {alpha}-reductase activities correlate significantly with seasonal reproductive cycles in goldfish (Carassius auratus). Endocrinology 122:1349–1356[Abstract/Free Full Text]
  7. Gelinas D, Callard GV 1993 Immunocytochemical and biochemical evidence for aromatase in neurons of the retina, optic tectum and retinotectal pathways in goldfish. J Neuroendocrinol 5:635–641[CrossRef][Medline]
  8. Gelinas D, Callard GV 1997 Immunolocalization of aromatase- and androgen receptor-positive neurons in the goldfish brain. Gen Comp Endocrinol 106:155–168[CrossRef][Medline]
  9. Stuermer CA, Bastmeyer M, Bahr M, Strobel G, Paschke K 1992 Trying to understand axonal regeneration in the CNS of fish. J Neurobiol 23:537–550[CrossRef][Medline]
  10. Tchoudakova A, Callard GV 1998 Identification of multiple CYP19 genes encoding different cytochrome P450 aromatase isozymes in brain and ovary. Endocrinology 139:2179–2189[Abstract/Free Full Text]
  11. Pasmanik M, Schlinger BA, Callard GV 1988 In vivo steroid regulation of aromatase and 5 alpha-reductase in goldfish brain and pituitary. Gen Comp Endocrinol 71:175–182[CrossRef][Medline]
  12. Gelinas D, Pitoc GA, Callard GV 1998 Isolation of a goldfish brain cytochrome P450 aromatase cDNA: mRNA expression during the seasonal cycle and after steroid treatment. Mol Cell Endocrinol 138:81–93[CrossRef][Medline]
  13. Westerfield M 1995 The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio rerio), ed 3. University of Oregon Press, Oregon
  14. Takahashi H 1977 Juvenile hermaphroditism in the zebrafish, Brachydanio rerio. Bull Fac Fish Hokkaido University 28:57–65
  15. Kishida M, McLellan M, Miranda JA, Callard GV Estrogen and xenoestrogens upregulate the brain aromatase isoform (P450aromB) and perturb markers of early development in zebrafish (Danio rerio). Comp Biochem Physiol, in press
  16. Piferrer F, Donaldson EM 1994 Uptake and clearance of exogenous estradiol-17ß and testosterone during the early development of coho salmon (Oncorhynchus kisutch), including eggs, alevins and fry. Fish Physiol Biochem 13:219–232
  17. Yeoh C-G, Schreck CB, Fitzpatrick MS, Feist GW 1996 In vivo steroid metabolism in embryonic and newly hatched steelhead trout (Oncorhynchus mykiss). Gen Comp Endocrinol 102:197–209[CrossRef][Medline]
  18. Khan MN, Renaud RL, Leatherland JF 1997 Metabolism of estrogens and androgens by embryonic tissues of Arctic charr, Salvelinus alpinus. Gen Comp Endocrinol 107:118–127[CrossRef][Medline]
  19. Thompson JD, Higgins DG, Gibson TJ 1994 CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680[Abstract/Free Full Text]
  20. Swofford DL 1998 PAUP: Phylogenetic Analysis Using Parsimony and Other Methods. Version 4, Sinauer Associates, Sunderland, MA
  21. Kozak M 1987 An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15:8125–8148[Abstract/Free Full Text]
  22. Trant JM 1994 Isolation and characterization of the cDNA encoding the channel catfish (Ictalurus punctatus) form of cytochrome P450arom. Gen Comp Endocrinol 95:155–168[CrossRef][Medline]
  23. Chang XT, Kobayashi T, Kajiura H, Nakamura M, Nagahama Y 1997 Isolation and characterization of the cDNA encoding the tilapia (Oreochromis niloticus) cytochrome P450 aromatase (P450arom): changes in P450arom mRNA, protein and enzyme activity in ovarian follicles during oogenesis. J Mol Endocrinol 18:57–66[Abstract/Free Full Text]
  24. Fukada S, Tanaka M, Matsuyama M, Kobayashi D, Nagahama Y 1996 Isolation, characterization, and expression of cDNAs encoding the medaka (Oryzias latipes) ovarian follicle cytochrome P-450 aromatase. Mol Reprod Dev 45:285–290[CrossRef][Medline]
  25. Tanaka M, Telecky TM, Fukada S, Adachi S, Chen S, Nagahama Y 1992 Cloning and sequence analysis of the cDNA encoding P-450 aromatase (P450arom) from a rainbow trout (Oncorhynchus mykiss) ovary; relationship between the amount of P450arom mRNA and the production of oestradiol-17ß in the ovary. J Mol Endocrinol 8:53–61[Abstract/Free Full Text]
  26. McPhaul MJ, Noble JF, Simpson ER, Mendelson CR, Wilson JD 1988 The expression of a functional cDNA encoding the chicken cytochrome P-450arom (aromatase) that catalyzes the formation of estrogen from androgen. J Biol Chem 263:16358–16363[Abstract/Free Full Text]
  27. Corbin CJ, Graham-Lorence S, McPhaul M, Mason JI, Mendelson CR, Simpson ER 1988 Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sci USA 85:8948–8952[Abstract/Free Full Text]
  28. Graham-Lorence S, Amarneh B, White RE, Peterson JA, Simpson ER 1995 A three-dimensional model of aromatase cytochrome P450. Protein Sci 4:1065–1080[Medline]
  29. Callard GV, Tchoudakova A 1997 Evolutionary and functional significance of two CYP19 genes differentially expressed in brain and ovary of goldfish. J Steroid Biochem Mol Biol 61:387–392[CrossRef][Medline]
  30. Corbin CJ, Trant JM, Walters KW, Conley AJ 1999 Changes in testosterone metabolism associated with the evolution of placental and gonadal isozymes of porcine aromatase cytochrome P450. Endocrinology 140:5202–5210[Abstract/Free Full Text]
  31. Choi I, Collante WR, Simmen RC, Simmen FA 1997 A developmental switch in expression from blastocyst to endometrial/placental-type cytochrome P450 aromatase genes in the pig and horse. Biol Reprod 56:688–696[Abstract]
  32. Force A, Lynch M, Pickett FB, Amores A, Yan YL, Postlethwait J 1999 Preservation of duplicate genes by complementary, degenerative mutations. Genetics 151:1531–1545[Abstract/Free Full Text]
  33. Pedersen RA 1998 Early mammalian embryogenesis. In: Knobil E, Neill JD, Ewing LL, Greenwald GS, Markert CL, Pfaff DW (eds) The Physiology of Reproduction. Raven Press, New York, vol 1:187–230
  34. Sidis Y, Fujiwara T, Leykin L, Isaacson K, Toth T, Schneyer AL 1998 Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: evidence for activin’s paracrine signaling from granulosa cells to oocytes. Biol Reprod 59:807–812[Abstract/Free Full Text]
  35. Patino R, Kagawa H 1999 Regulation of gap junctions and oocyte maturational competence by gonadotropin and insulin-like growth factor-I in ovarian follicles of red seabream. Gen Comp Endocrinol 115:454–462[CrossRef][Medline]
  36. Boerboom D, Kerban A, Sirois J 1999 Dual regulation of promoter II- and promoter 1f-derived cytochrome P450 aromatase transcripts in equine granulosa cells during human chorionic gonadotropin-induced ovulation: a novel model for the study of aromatase promoter switching. Endocrinology 140:4133–4141[Abstract/Free Full Text]
  37. Bashirullah A, Cooperstock RL, Lipshitz HD 1998 RNA localization in development. Annu Rev Biochem 67:335–394[CrossRef][Medline]
  38. Pelegri F, Schulte-Merker S 1999 A gynogenesis-based screen for maternal-effect genes in the zebrafish, Danio rerio. In: Detrich H, Westerfield, M, Leonard IZ (eds) The Zebrafish: Genetics and Genomics. Academic Press, Tubingen, Germany, vol 60:1–20
  39. Yoon C, Kawakami K, Hopkins N 1997 Zebrafish vasa homologue RNA is localized to the cleavage planes of 2- and 4-cell-stage embryos and is expressed in the primordial germ cells. Development 124:3157–3165[Abstract]
  40. Conley AJ, Christenson LK, Ford SP, Christenson RK 1994 Immunocytochemical localization of cytochromes P450 17{alpha}-hydroxylase and aromatase in embryonic cell layers of elongating porcine blastocysts. Endocrinology 135:2248–2254[Abstract/Free Full Text]
  41. Walters KW, Corbin CJ, Anderson GB, Roser JF, Conley AJ 2000 Tissue-specific localization of cytochrome P450 aromatase in the equine embryo by in situ hybridization and immunocytochemistry. Biol Reprod 62:1141–1145[Abstract/Free Full Text]
  42. Arey LB 1946 Developmental Anatomy. A Textbook and Laboratory Manual of Embryology. W. B. Saunders, Philadelphia
  43. Lephart ED, Simpson ER, McPhaul MJ, Kilgore MW, Wilson JD, Ojeda SR 1992 Brain aromatase cytochrome P-450 messenger RNA levels and enzyme activity during prenatal and perinatal development in the rat. Brain Res Mol Brain Res 16:187–192[Medline]
  44. Abe-Dohmae S, Takagi Y, Harada N 1997 Autonomous expression of aromatase during development of mouse brain is modulated by neurotransmitters. J Steroid Biochem Mol Biol 61:299–306[CrossRef][Medline]
  45. Jeyasuria P, Place AR 1998 Embryonic brain-gonadal axis in temperature-dependent sex determination of reptiles: a role for P450 aromatase (CYP19). J Exp Zool 281:428–449[CrossRef][Medline]
  46. Greco TL, Payne AH 1994 Ontogeny of expression of the genes for steroidogenic enzymes P450 side-chain cleavage, 3ß-hydroxysteroid dehydrogenase, P450 17{alpha}-hydroxylase/C17–20 lyase, and P450 aromatase in fetal mouse gonads. Endocrinology 135:262–268[Abstract]
  47. Kitano T, Takamune K, Kobayashi T, Nagahama Y, Abe SI 1999 Suppression of P450 aromatase gene expression in sex-reversed males produced by rearing genetically female larvae at a high water temperature during a period of sex differentiation in the Japanese flounder (Paralichthys olivaceus). J Mol Endocrinol 23:167–176[Abstract]
  48. Guiguen Y, Baroiller JF, Ricordel MJ, Iseki K, McMeel OM, Martin SA, Fostier A 1999 Involvement of estrogens in the process of sex differentiation in two fish species: the rainbow trout (Oncorhynchus mykiss) and a tilapia (Oreochromis niloticus). Mol Reprod Dev 54:154–162[CrossRef][Medline]
  49. Roselli CE, Klosterman SA 1998 Sexual differentiation of aromatase activity in the rat brain: effects of perinatal steroid exposure. Endocrinology 139:3193–3201[Abstract/Free Full Text]
  50. Hou Q, Gorski J 1993 Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development. Proc Natl Acad Sci USA 90:9460–9464[Abstract/Free Full Text]
  51. Tanaka M, Fukada S, Matsuyama M, Nagahama Y 1995 Structure and promoter analysis of the cytochrome P-450 aromatase gene of the teleost fish, medaka (Oryzias latipes). J Biochem (Tokyo) 117:719–725[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Biol. Reprod.Home page
K. Mouriec, M.-M. Gueguen, C. Manuel, F. Percevault, M.-L. Thieulant, F. Pakdel, and O. Kah
Androgens Upregulate cyp19a1b (Aromatase B) Gene Expression in the Brain of Zebrafish (Danio rerio) Through Estrogen Receptors
Biol Reprod, May 1, 2009; 80(5): 889 - 896.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
Y. Zhang, W. Zhang, H. Yang, W. Zhou, C. Hu, and L. Zhang
Two cytochrome P450 aromatase genes in the hermaphrodite ricefield eel Monopterus albus: mRNA expression during ovarian development and sex change
J. Endocrinol., November 1, 2008; 199(2): 317 - 331.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. Lange, Y. Katsu, R. Ichikawa, G. C. Paull, L. L. Chidgey, T. S. Coe, T. Iguchi, and C. R. Tyler
Altered Sexual Development in Roach (Rutilus rutilus) Exposed to Environmental Concentrations of the Pharmaceutical 17{alpha}-Ethinylestradiol and Associated Expression Dynamics of Aromatases and Estrogen Receptors
Toxicol. Sci., November 1, 2008; 106(1): 113 - 123.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
Z. Liu, F. Wu, B. Jiao, X. Zhang, C. Hu, B. Huang, L. Zhou, X. Huang, Z. Wang, Y. Zhang, et al.
Molecular cloning of doublesex and mab-3-related transcription factor 1, forkhead transcription factor gene 2, and two types of cytochrome P450 aromatase in Southern catfish and their possible roles in sex differentiation
J. Endocrinol., July 1, 2007; 194(1): 223 - 241.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. Lyssimachou, B. M. Jenssen, and A. Arukwe
Brain Cytochrome P450 Aromatase Gene Isoforms and Activity Levels in Atlantic Salmon After Waterborne Exposure to Nominal Environmental Concentrations of the Pharmaceutical Ethynylestradiol and Antifoulant Tributyltin
Toxicol. Sci., May 1, 2006; 91(1): 82 - 92.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
Y Kazeto and J M Trant
Molecular biology of channel catfish brain cytochrome P450 aromatase (CYP19A2): cloning, preovulatory induction of gene expression, hormonal gene regulation and analysis of promoter region
J. Mol. Endocrinol., December 1, 2005; 35(3): 571 - 583.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. D. Costache, P. K. Pullela, P. Kasha, H. Tomasiewicz, and D. S. Sem
Homology-Modeled Ligand-Binding Domains of Zebrafish Estrogen Receptors {alpha}, {beta}1, and {beta}2: From in Silico to in Vivo Studies of Estrogen Interactions in Danio rerio as a Model System
Mol. Endocrinol., December 1, 2005; 19(12): 2979 - 2990.
[Abstract] [Full Text] [PDF]


Home page
Proc R Soc BHome page
M. P Black, J. Balthazart, M. Baillien, and M. S Grober
Socially induced and rapid increases in aggression are inversely related to brain aromatase activity in a sex-changing fish, Lythrypnus dalli
Proc R Soc B, November 22, 2005; 272(1579): 2435 - 2440.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
R Mindnich, F Haller, F Halbach, G Moeller, M H. de Angelis, and J Adamski
Androgen metabolism via 17{beta}-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme
J. Mol. Endocrinol., October 1, 2005; 35(2): 305 - 316.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
S. Kuntz, A. Chesnel, S. Flament, and D. Chardard
Cerebral and gonadal aromatase expressions are differently affected during sex differentiation of Pleurodeles waltl
J. Mol. Endocrinol., December 1, 2004; 33(3): 717 - 727.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Miguel-Queralt, M. Knowlton, G. V. Avvakumov, R. Al-Nouno, G. M. Kelly, and G. L. Hammond
Molecular and Functional Characterization of Sex Hormone Binding Globulin in Zebrafish
Endocrinology, November 1, 2004; 145(11): 5221 - 5230.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
W. Tadros, S. A. Houston, A. Bashirullah, R. L. Cooperstock, J. L. Semotok, B. H. Reed, and H. D. Lipshitz
Regulation of Maternal Transcript Destabilization During Egg Activation in Drosophila
Genetics, July 1, 2003; 164(3): 989 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. M. Spitsbergen and M. L. Kent
The State of the Art of the Zebrafish Model for Toxicology and Toxicologic Pathology Research--Advantages and Current Limitations
Toxicol Pathol, January 1, 2003; 31(1_suppl): 62 - 87.
[Abstract] [PDF]


Home page
Toxicol SciHome page
G. T. Ankley, M. D. Kahl, K. M. Jensen, M. W. Hornung, J. J. Korte, E. A. Makynen, and R. L. Leino
Evaluation of the Aromatase Inhibitor Fadrozole in a Short-Term Reproduction Assay with the Fathead Minnow (Pimephales promelas)
Toxicol. Sci., May 1, 2002; 67(1): 121 - 130.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
D. Uchida, M. Yamashita, T. Kitano, and T. Iguchi
Oocyte apoptosis during the transition from ovary-like tissue to testes during sex differentiation of juvenile zebrafish
J. Exp. Biol., March 15, 2002; 205(6): 711 - 718.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. R. Simpson and S. R. Davis
Minireview: Aromatase and the Regulation of Estrogen Biosynthesis--Some New Perspectives
Endocrinology, November 1, 2001; 142(11): 4589 - 4594.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Okubo, S. Nagata, R. Ko, H. Kataoka, Y. Yoshiura, H. Mitani, M. Kondo, K. Naruse, A. Shima, and K. Aida
Identification and Characterization of Two Distinct GnRH Receptor Subtypes in a Teleost, the Medaka Oryzias latipes
Endocrinology, November 1, 2001; 142(11): 4729 - 4739.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kishida, M.
Right arrow Articles by Callard, G. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kishida, M.
Right arrow Articles by Callard, G. V.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
Medline Plus Health Information
*Seniors' Health


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals